Erste Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Erste Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.79M	Hold	71,800	–	–	0.05%	287
2026 Q1	$5.21M	Hold	71,800	–	–	0.05%	268
2025 Q4	$5.74M	Hold	71,800	–	–	0.05%	254
2025 Q3	$4.61M	Buy	71,800 +20,500	+40%	+$1M	0.04%	263
2025 Q2	$2.04M	Hold	51,300	–	–	0.02%	393
2025 Q1	$1.6M	Hold	51,300	–	–	0.02%	329
2024 Q4	$1.84M	Hold	51,300	–	–	0.02%	336
2024 Q3	$2.1M	Hold	51,300	–	–	0.03%	316
2024 Q2	$2.42M	Hold	51,300	–	–	0.03%	291
2024 Q1	$2.29M	Hold	51,300	–	–	0.03%	290
2023 Q4	$2.59M	Hold	51,300	–	–	0.04%	272
2023 Q3	$2.37M	Hold	51,300	–	–	0.04%	258
2023 Q2	$2.11M	Hold	51,300	–	–	0.04%	284
2023 Q1	$1.79M	Hold	51,300	–	–	0.03%	288
2022 Q4	$1.92M	Hold	51,300	–	–	0.04%	280
2022 Q3	$2.27M	Hold	51,300	–	–	0.05%	272
2022 Q2	$1.93M	Hold	51,300	–	–	0.04%	285
2022 Q1	$1.83M	Hold	51,300	–	–	0.03%	305
2021 Q4	$1.57M	Hold	51,300	–	–	0.03%	320
2021 Q3	$1.72M	Hold	51,300	–	–	0.03%	287
2021 Q2	$2.03M	Buy	51,300 +16,800	+49%	+$658K	0.04%	279
2021 Q1	$1.54M	Sell	34,500 -17,000	-33%	-$948K	0.04%	300
2020 Q4	$2.94M	Sell	51,500 -6,500	-11%	-$324K	0.08%	227
2020 Q3	$2.81M	Sell	58,000 -2,660	-4%	-$148K	0.1%	208
2020 Q2	$3.6M	Sell	60,660 -1,470	-2%	-$81.8K	0.14%	159
2020 Q1	$2.99M	Sell	62,130 -4,116	-6%	-$229K	0.17%	147
2019 Q4	$4.02M	Buy	66,246 +3,046	+5%	+$181K	0.18%	131
2019 Q3	$3.73M	Hold	63,200	–	–	0.2%	127
2019 Q2	$4.09M	Buy	63,200 +15,200	+32%	+$1.07M	0.22%	118
2019 Q1	$3.83M	Buy	+48,000	New	+$3.1M	0.21%	114

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Erste Asset Management's IONS Position: Q2 2026 in Review

Erste Asset Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 71,800 shares worth $5.79M. The position accounts for 0.05% of the portfolio, ranked #287.

Erste Asset Management first reported a position in IONS in Q1 2019 and has held it in 30 quarters since. 513 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Erste Asset Management held 71,800 shares of Ionis Pharmaceuticals worth $5.79M as of Q2 2026.
Erste Asset Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up 0.05% of Erste Asset Management's portfolio in Q2 2026, its #287 holding.
Erste Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
513 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.